Drug intelligence / Profile preview

acetaminophen + etoricoxib + tramadol

Development stage
Preclinical
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination drug consisting of three active pharmaceutical ingredients: - **Acetaminophen (paracetamol):** A non-opioid analgesic and antipyretic that works primarily by inhibiting prostaglandin synthesis in the central nervous system, leading to reduced pain and fever. - **Etoricoxib:** A selective cyclooxygenase-2 (COX-2) inhibitor classified as a nonsteroidal anti-inflammatory drug (NSAID). It reduces inflammation and pain by selectively blocking COX-2, an enzyme involved in prostaglandin production. - **Tramadol:** An opioid analgesic that acts as a weak agonist at the μ-opioid receptor and also inhibits reuptake of norepinephrine and serotonin, contributing to its analgesic effects. The rationale for combining these agents is to provide multimodal analgesia—targeting different pain pathways—to achieve superior pain relief with potentially lower doses of each component. This approach may reduce side effects associated with higher doses of individual drugs. While combinations such as acetaminophen/tramadol or etoricoxib/tramadol are studied for acute low back pain and other painful conditions[1][2][3][5], there is limited evidence or commercial availability for a fixed-dose triple combination containing all three agents together.

02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)SERT (Sodium-dependent serotonin transporter)CNR1 (Cannabinoid receptor 1)NET (Norepinephrine Transporter)MOR (Mu opioid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on acetaminophen + etoricoxib + tramadol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + etoricoxib + tramadol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call